Paul Gerhardt S.
- Country
- Germany
- Department
- Universitätskinderklinik, Hämatologie und Onkologie
Research Overview
- Evaluation of Melphalan-Based Chemotherapy Regimens in Low and Intermediate Risk Neuroblastoma: A Multicenter, Prospective Study
- International multicenter, open-label clinical trial for the treatment of acute myeloid leukemia in children and adolescents
- Nivolumab in combination with cisplatin and 5-fluorouracil as induction therapy in children and adults with EBV-positive nasopharyngeal carcinoma
Data & Insights
Has run more than one trial at 131 of 218 partner sites.
Specializations
Pediatric Solid Tumors
The investigator specializes in treating hepatoblastoma, hepatocellular carcinoma, and rhabdomyosarcoma. Their research extends to neuroblastoma and various forms of brain tumors, including medulloblastoma, ependymoma, and atypical teratoid/rhabdoid tumors.
- Liver Cancers
- Soft Tissue Sarcomas
- Central Nervous System Tumors
Hematologic Malignancies
Primary focus on pediatric blood cancers, particularly acute lymphoblastic leukemia and acute myeloid leukemia. The investigator has extensive experience with Philadelphia chromosome-positive ALL and lymphoblastic lymphoma.
- Leukemia Treatment Protocols
- Stem Cell Transplantation
- Novel Therapeutic Approaches
Specialized Treatments
Expertise in CAR T-cell therapy and other innovative treatments including targeted therapies for germ cell tumors and nasopharyngeal carcinoma. The investigator works with both conventional and experimental therapeutic approaches.
- Immunotherapy
- Precision Medicine
- Clinical Trial Development
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.